TY - JOUR
T1 - Effects of multiwavelength photobiomodulation for the treatment of traumatic soft tissue injuries associated with bone fractures
T2 - A double-blind, randomized controlled clinical trial
AU - Jana Neto, Frederico Carlos
AU - Martimbianco, Ana Luiza Cabrera
AU - Mesquita-Ferrari, Raquel Agnelli
AU - Bussadori, Sandra Kalil
AU - Alves, Gustavo Porto
AU - Almeida, Paulo Victor Dias
AU - Delgado, Felipe Guimaraes
AU - Fonseca, Lucas Resende
AU - Gama, Maiara Zeni Graiff
AU - Jorge, Mariana Djrdjrjan
AU - Hamblin, Michael R.
AU - Fernandes, Kristianne Porta Santos
N1 - Publisher Copyright:
© 2023 Wiley-VCH GmbH.
PY - 2023/5
Y1 - 2023/5
N2 - This study evaluated the efficacy and safety of multiwavelength photobiomodulation (MPBM) in healing soft tissue injuries associated with tibial and/or ankle fractures. Participants were randomized into the MPBM or control group. Primary outcome was wound healing, measured by the Bates-Jensen scale. Assessments were performed daily. Twenty-seven hospitalized adults were included. MPBM showed an improvement in the daily mean Bates-Jensen scale (MPBM 32.1 vs. control 34.2; p = 0.029), daily mean pain score change (MPBM 0.5 vs. control 0.2; p = 0.04) and occurrence of infection at the site of the external fixator pins (MPBM 15.3% vs. control 57.1%; p = 0.02). MPBM group also showed faster-wound resolution (MPBM 13.1 vs. control 23.1 days). Subgroup analysis showed improvement in the MPBM group among less severe patients on the Bates-Jensen scale (MPBM 27.4 vs. control 34.7; p = 0.0081) and mean time for wound resolution (MPBM 7.0 vs. control 14.6 days; p = 0.03). MPBM appears safe and effective in reducing wound resolution time, infection in the surgical pin sites, reported pain and time before definitive surgery.
AB - This study evaluated the efficacy and safety of multiwavelength photobiomodulation (MPBM) in healing soft tissue injuries associated with tibial and/or ankle fractures. Participants were randomized into the MPBM or control group. Primary outcome was wound healing, measured by the Bates-Jensen scale. Assessments were performed daily. Twenty-seven hospitalized adults were included. MPBM showed an improvement in the daily mean Bates-Jensen scale (MPBM 32.1 vs. control 34.2; p = 0.029), daily mean pain score change (MPBM 0.5 vs. control 0.2; p = 0.04) and occurrence of infection at the site of the external fixator pins (MPBM 15.3% vs. control 57.1%; p = 0.02). MPBM group also showed faster-wound resolution (MPBM 13.1 vs. control 23.1 days). Subgroup analysis showed improvement in the MPBM group among less severe patients on the Bates-Jensen scale (MPBM 27.4 vs. control 34.7; p = 0.0081) and mean time for wound resolution (MPBM 7.0 vs. control 14.6 days; p = 0.03). MPBM appears safe and effective in reducing wound resolution time, infection in the surgical pin sites, reported pain and time before definitive surgery.
KW - bone fracture
KW - multiwavelength LED
KW - non-pharmaceutical pain control
KW - photobiomodulation
KW - randomized placebo-controlled clinical trial
UR - http://www.scopus.com/inward/record.url?scp=85147523195&partnerID=8YFLogxK
U2 - 10.1002/jbio.202200299
DO - 10.1002/jbio.202200299
M3 - Article
C2 - 36640122
AN - SCOPUS:85147523195
SN - 1864-063X
VL - 16
JO - Journal of Biophotonics
JF - Journal of Biophotonics
IS - 5
M1 - e202200299
ER -